Form 4: Elevance Health Executive Peter Haytaian Reports Stock Transactions

Elevance Health's EVP & President Carelon & CarelonRx, Peter D Haytaian, reports acquisition and disposal of company stock and derivative securities.

Summary

• Peter D Haytaian, an EVP & President Carelon & CarelonRx at Elevance Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 3, 2025, Haytaian disposed of 2,281 shares of common stock to cover tax liabilities at a price of $395.5 per share.
• On the same date, Haytaian acquired 3,035 restricted share units and 4,213 performance-based restricted share units at $0.
• Haytaian also acquired an option to purchase 11,549 shares of common stock at an exercise price of $395.5, exercisable in installments starting March 3, 2026.
• Following these transactions, Haytaian beneficially owns 26,004 shares of common stock and 11,549 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The acquisition of shares and options could be seen as a positive sign, but the disposal of shares for tax liabilities is a normal occurrence.

Positives

• The acquisition of restricted share units and performance-based restricted share units suggests confidence in the company's future performance.
• The granting of stock options aligns the executive's interests with those of the shareholders.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules for restricted stock units extend to 2028, and the stock options expire in 2035, suggesting a long-term perspective.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation in the healthcare industry, used to align management's interests with shareholder value.
• Vesting schedules and exercise prices are typically structured to incentivize long-term performance and retention.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar compensation strategies for their executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly diluting the stock if the options are exercised in the future.
• Employees may be impacted positively by the executive's continued investment in the company.

Key Dates